User login
CHEST welcomed Peter J. Mazzone, MD, MPH, FCCP, in July, as the new Editor in Chief of the journal CHEST®. Dr. Mazzone is the Director of the Lung Cancer Program and Lung Cancer Screening Program for the Respiratory Institute at the Cleveland Clinic in Ohio.
His clinical interests include nodule management and the prevention, screening, diagnosis, staging, and characterization of lung cancer; his research has focused on the development of molecular biomarkers for lung cancer detection. Dr. Mazzone has been a member of CHEST since 1999 and an FCCP since 2004. He has served in several CHEST leadership positions, including member of the CHEST Lung Cancer Living Guidelines Steering Committee and program chair for the CHEST 2017 annual meeting, among others. Dr. Mazzone has provided some insights into the structure and strategies of the journal going forward, so don’t miss his editorial in the July issue of CHEST®.
CHEST welcomed Peter J. Mazzone, MD, MPH, FCCP, in July, as the new Editor in Chief of the journal CHEST®. Dr. Mazzone is the Director of the Lung Cancer Program and Lung Cancer Screening Program for the Respiratory Institute at the Cleveland Clinic in Ohio.
His clinical interests include nodule management and the prevention, screening, diagnosis, staging, and characterization of lung cancer; his research has focused on the development of molecular biomarkers for lung cancer detection. Dr. Mazzone has been a member of CHEST since 1999 and an FCCP since 2004. He has served in several CHEST leadership positions, including member of the CHEST Lung Cancer Living Guidelines Steering Committee and program chair for the CHEST 2017 annual meeting, among others. Dr. Mazzone has provided some insights into the structure and strategies of the journal going forward, so don’t miss his editorial in the July issue of CHEST®.
CHEST welcomed Peter J. Mazzone, MD, MPH, FCCP, in July, as the new Editor in Chief of the journal CHEST®. Dr. Mazzone is the Director of the Lung Cancer Program and Lung Cancer Screening Program for the Respiratory Institute at the Cleveland Clinic in Ohio.
His clinical interests include nodule management and the prevention, screening, diagnosis, staging, and characterization of lung cancer; his research has focused on the development of molecular biomarkers for lung cancer detection. Dr. Mazzone has been a member of CHEST since 1999 and an FCCP since 2004. He has served in several CHEST leadership positions, including member of the CHEST Lung Cancer Living Guidelines Steering Committee and program chair for the CHEST 2017 annual meeting, among others. Dr. Mazzone has provided some insights into the structure and strategies of the journal going forward, so don’t miss his editorial in the July issue of CHEST®.